Judge Won't Toss Teva's Migraine Drug IP Suit Against Eli Lilly
A Massachusetts federal judge refused on Tuesday to boot Teva Pharmaceutical's patent suit against rival Eli Lilly over a competing migraine medication, ruling that Eli Lilly was relying on claim construction...To view the full article, register now.
Already a subscriber? Click here to view full article